Results 111 to 120 of about 11,409 (147)
Allergen Immunotherapy and 36‐Month Allergic Respiratory Disease Trajectories: A Target‐Trial
Among 2,713 patients with allergic respiratory disease eligible for allergen immunotherapy (AIT), target‐trial compared 1,971 AIT initiators with 742 eligible non‐initiators over 36 months. AIT initiation was associated with less clinically meaningful worsening (46.3% vs 63.6%; RR 0.73), more clinical remission (47.0% vs 18.3%; RR 2.57), more treatment‐
Víctor Gonzalez‐Uribe +7 more
wiley +1 more source
Introduction: Fractional exhaled nitric oxide (FeNO) testing has been implemented in some areas of England, predominantly for asthma diagnosis. This study is nested in an ongoing randomised controlled trial investigating use of FeNO testing and a FeNO ...
Lewis, Grace M +8 more
core +1 more source
Clinical &Experimental Allergy, Volume 55, Issue 3, Page 264-266, March 2025.
Kirsten E. Stewart +3 more
wiley +1 more source
A 74‐year‐old woman was treated for 7 years as culture‐negative bronchiectasis before palpable purpura, haemoptysis, and acute kidney injury revealed MPO‐ANCA vasculitis with pauci‐immune crescentic glomerulonephritis. Rituximab‐based induction produced near‐complete resolution of the pulmonary consolidations and sustained clinical remission at 15 ...
Andrew Kim +5 more
wiley +1 more source
Very Long‐Term Stability of Tryptase in Frozen Serum Samples
Clinical &Experimental Allergy, Volume 55, Issue 3, Page 276-277, March 2025.
Florent Broussal +7 more
wiley +1 more source
Nasal epithelial transcriptomics identified three cytokine‐associated epithelial immune programs linked to childhood asthma phenotypes. Age‐associated epithelial polarization shifted from IFN/type‐17‐associated toward type‐2‐associated programs after 3 years of age.
Constanze A. Jakwerth +71 more
wiley +1 more source
Updates in COPD Management: From Inflammatory Pathways to Targeted Therapies
COPD is a heterogeneous disease driven by overlapping neutrophilic and eosinophilic inflammatory pathways. This review highlights the shift from symptom‐based treatment toward phenotype‐ and biomarker‐directed care. Blood eosinophils, FeNO, and IgE predict corticosteroid responsiveness and identify candidates for biologic therapy.
Sasha Raman +3 more
wiley +1 more source
Relación de los niveles de FeNO con la gravedad del asma: estudio transversal en el Hospital Universitario de Puebla [PDF]
Introducción: La evaluación del paciente con asma utiliza herramientas clínicas como el Asthma Control Test (ACT), pruebas de función pulmonar y biomarcadores.
Aida Inés López García +5 more
core +1 more source
Machine learning models applied to detailed early‐life data showed limited ability to predict which children developed persistent asthma or allergic rhinitis. Although clinically plausible features contributed to predictions, model performance was insufficient for reliable individual prognostic stratification.
Frederikke Rosenvinge Skov +8 more
wiley +1 more source
FeNO and Exercise Testing in Children at Risk of Asthma
Background: Exercise testing is the gold standard for diagnosing exercise-induced bronchoconstriction in children, but requires considerable cooperation and medical resources. Therefore, fraction of exhaled nitric oxide (FeNO) has been proposed as a tool
Ann-Marie Malby Schoos +11 more
core +1 more source

